Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.87

-2.3%

Dec 5 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who started this subject	6/25/2002 8:45:08 PM
From: Ian@SI	Read Replies (1) of 52153

Courts continue to protect Pharma / Biotech's IP. If this doesn't help increase valuations, perhaps it will slow the rate of decline... :-( AstraZeneca: court dismisses Prilosec "sham litigation" claims (AZN) 40.99 +0.77: Announces that a U.S. District Court Judge has dismissed 2 federal class action antitrust lawsuits brought by consumers and third-party payors against AZN; the judge concluded that the plaintiffs failed to demonstrate that the Prilosec patent infringement litigation brought by AZN against 10 generic manufacturers was a "sham" or an unlawful attempt to prevent generic competitors from entering the mkt.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next